|
|
||||||||
Articles |
1
Biochem Laboratory, Emile Roux Hospital, AP-HP, 1 Avenue de Verdun, 94456 Limeil-Brévannes Cedex, France.
2
Biology Laboratory, Joffre-Dupuytren Hospital, AP-HP,
91211 Draveil Cedex, France.
3
Biochem Laboratory, Hôtel-Dieu Hospital, AP-HP, 1
Place du Parvis Notre-Dame, 75181 Paris Cedex 04, France.
4
Nutrition Laboratory, EA 2498, Paris V University, 4
Avenue de lObservatoire, 75006 Paris, France.
a Address correspondence to this author at: Laboratoire de Biologie, Hôpital Joffre-Dupuytren, 1, Rue Louis Camatte, 91211 Draveil Cedex, France. Fax 33-1-69-83-6495; e-mail f.blonde-cynober{at}jfr.ap-hop-paris.fr
| Abstract |
|---|
|
|
|---|
Methods: Four keto-acids (
-ketoisocaproate,
-ketoisovalerate,
-keto-ß-methylvalerate, and pyruvate) were
derivatized with o-phenylenediamine to give fluorescent
derivatives. After the sample preparation step (75 min to prepare 20
samples), the derivatives were separated chromatographically on a
reversed-phase column using a binary gradient.
Results: The fluorometric detection of the four keto-acids
was rapid, <12 min. The method is repeatable and reproducible:
the CVs were <6% and <11%, respectively, for each of the
keto-acids. We found no significant difference between males and
females. Concentrations of the branched-chain keto-acids decreased
after age 60 years, especially
-ketoisocaproate, which decreased
~40%.
Conclusions: The proposed method allows rapid and reliable measurement of keto-acids. The data demonstrate that changes in branched-chain keto-acids concentrations in serum occur with age.
| Introduction |
|---|
|
|
|---|
-ketoisocaproate (KIC),
-ketoisovalerate (KIV),
and
-keto-ß-methylvalerate (KMV). BCKAs are glucogenic (KIV and
KMV) or ketogenic (KIC and KMV) precursors (1) and can
regulate protein turnover (2)(3)(4). Hence, the investigation
of BCKA metabolism is of interest for pathological situations such as
sepsis (5), burns (6), and in hepatic disorders
(7). Another keto-acid, pyruvate (PYR), is at a metabolic
crossroads and is notably involved in alanine biosynthesis. It is
therefore also important to follow the changes in its concentration in
hypercatabolic states (6)(8)(9). A
higher risk of infectious diseases has been reported in elderly people,
particularly those living in institutions, because of protein
malnutrition and a decline in the immune system (10). In
these clinical latter situations, the measurement of keto-acids in
venous blood is therefore of relevance. To the best of our knowledge,
no prior work on this topic has been reported. Many methods based on gas chromatography, using derivatives such as quinoxalinols (11)(12) or oximes (13)(14), and HPLC (15)(16)(17)(18)(19)(20)(21)(22) currently are used for the determination of keto-acids. However, many of these techniques are time-consuming.
The first purpose of this study was to develop, for clinical use, a reliable HPLC technique with fluorometric detection based on quinoxalinol derivatives for the determination in serum of BCKAs and pyruvate, using o-phenylenediamine (OPD) as a fluorogenic agent. Its second aim was to assess the blood concentrations of keto-acids in adults and elderly institutionalized people.
| Materials and Methods |
|---|
|
|
|---|
The OPD solution was prepared by dissolving 133 mg of OPD in 100 mL of 3 mol/L hydrochloric acid.
Methanol was HPLC grade (J.T. Baker). Distilled water was used for the preparation of all aqueous solutions.
Each component of the mobile phase (methanol and water) was filtered through 0.45 µm filters (type HV; Millipore), and then degassed ultrasonically before use.
Serum albumin concentrations were determined using the bromcresol green method (reagent from Boehringer) adapted to a multiparametric analyzer (911 Hitachi; Boehringer).
chromatographic conditions
The chromatographic system consisted of a model 680 automated
gradient controller, a syringe-loading sample injector containing a
20-µL loop, two model 510 pumps, and a model 470 scanning
fluorescence detector (all from Waters), a Spherisorb ODS-2
RP-18 column (250 x 4.6 mm; 5 µm particles) from Hypersil, and
a column oven (Touzart Matignon).
Retention times and peak areas were determined by a model 746 integrator (Waters) set with an attenuation of 128.0 and a chart speed of 0.5 cm/min. The serum keto-acid concentrations were calculated with the internal standard (IS) method.
calibrators
Because KV does not occur in human serum, KV was used as an IS. A
stock solution of KV was prepared at the concentration of 3.62 mmol/L
and stored at -20 °C.
Individual stock aqueous solutions of PYR (4.55 mmol/L), KIC (3.29 mmol/L), KIV (3.62 mmol/L), and KMV (3.29 mmol/L) were prepared and stored at -20 °C. The working calibration mixture was then prepared by mixing the four stock solutions in various proportions in water to obtain final concentrations of 164.4 µmol/L for KIC, 36.2 µmol/L for KIV, 32.8 µmol/L for KMV, and 45.5 µmol/L for PYR.
subjects
For the determination of blood concentrations, sera were obtained
from fasting healthy adult volunteers (25 men, 26 women), 1959 years
of age (mean ± SD, 40.0 ± 9.9 years), and from
elderly people in an institution (25 men, 25 women), 6099 years of
age (81.3 ± 10.3 years). This study was performed in accordance
with the current revision of the Helsinki Declaration of 1975. No
elderly patient had total parenteral or enteral nutrition, but some had
oral supplementation. All subjects exhibited normal hepatic function.
pretreatment of samples
Samples were deproteinated by the addition 50 mg of sulfosalicylic
acid to 1 mL of serum. After vortex-mixing for 15 s, the mixture
was kept at 4 °C for 10 min and then centrifuged at 2500g
for 10 min. The supernatant was removed and frozen at -20 °C until
analyzed.
Three distinct serum pools, collected randomly among hospitalized patients, were prepared in the same way. These pools were used to determine, respectively, the repeatability, the reproducibility, and the recoveries of the technique.
sample preparation
The conversion of keto-acids to the corresponding quinoxalinol
derivatives was adapted from the procedure of Koike and Koike
(15), and was as follows.
Samples and calibrators were thawed at room temperature. The IS (20 µL) and OPD (3 mL) were added to 250 µL of serum or to 500 µL of the calibration mixture in glass tubes. The derivatization was performed by heating the mixtures at 80 °C for 20 min. The samples were then cooled in an ice-water bath. Sodium sulfate (0.5 g) was added to each tube, and the quinoxalinol derivatives were extracted by 3 mL of ethyl acetate. The tubes were vortex-mixed for 1 min and then centrifuged. The upper ethyl acetate phase was transferred to a tube containing 0.5 g of sodium sulfate. After mixing and separation, the organic phase was evaporated to dryness under a stream of nitrogen at 37 °C (N-Evap model 111 evaporator; Organomation). The residue was then dissolved in 500 µL of methanol and filtered before injection.
hplc analysis
Samples (20 µL) of diluted derivatives were injected into the
column. Keto-acids were chromatographed at 50 °C by a gradient at a
flow rate of 1.6 mL/min. The composition of the mobile phase was as
follows: the starting mobile phase consisted of 200 mL/L
methanol800 mL/L water. The mobile phase composition
was changed by a linear gradient to 500 mL/L methanol500 mL/L
water over the course of 2 min. This composition was maintained for 1
min. Thereafter, a linear gradient elution was started, with a final
concentration of 800 mL/L methanol at 10 min. The original conditions
were then reestablished by a reverse gradient to 200 mL/L methanol800
mL/L water from the 10th to 11th minutes.
The quinoxalinol derivatives of BCKAs were detected by monitoring the fluorescence emission at 410 nm (with excitation at 350 nm).
statistics
All of the data presented are expressed as the mean ± SD.
Statistical significance was determined using the nonparametric
MannWhitney test. Differences with P values <0.05 were
considered significant.
| Results and Discussion |
|---|
|
|
|---|
|
The HPLC method used here affords chromatograms that are easy to interpret, with a stable baseline and good peak separation. This HPLC technique permits the measurement of four keto-acids in less than 12 min. This speed has not been obtained with other techniques using either OPD as fluorogenic agent (15)(18)(19) (1626 min), or 1,2-diamino-4,5-methylenedioxybenzene (21) (20 min). One technique based on the detection of 1,2-diamino-4,5-dimethoxybenzene derivatives gives the four keto-acids in almost the same time, i.e., within 14 min (22). However, in this latter technique, the preparation of the samples, in particular the derivatization, is time-consuming (2.5 h).
method validation (analytical variables)
Linearity and limit of detection.
For injected samples
(calibration solutions) in the range 13000 µmol/L (2060 nmol in
20 µL of injected samples), the detector response was linear
(r2 >0.996) for each keto-acid.
The limit of detection was determined as the concentration corresponding to a signal 3 SD above the mean for a calibrator free of analyte. This limit of detection for each keto-acid was 1 µmol/L, i.e., well below the physiological range (15)(18)(21)(22).
Precision.
We assessed the within-batch precision of the whole
method by 30 treatments of a pool of serum and then 30 individual
injections a day (repeatability). The between-batch precision was
measured after preparing and analyzing a sample from a pool of serum 12
times in 12 different experiments (reproducibility). The results are
presented in Table 1
.
|
The CV for the determination of the within-batch precision was <6% for all compounds investigated. The CV for the determination of the between-batch precision was <11% for all compounds investigated.
Recovery.
To estimate the influence of the deproteinization
process and sample preparation on the measurement of keto-acids, the
recoveries of keto-acids added to a pool of serum were determined. The
recoveries (mean ± SD) of keto-acids are presented in Table 2
. Recoveries were 97109% for PYR, 8794% for KIV, 9095%
for KIC, and 8691% for KMV. Every keto-acid was satisfactorily
recovered in comparison with other techniques
(18)(21) for all concentrations added (80640
µmol/L).
|
blood concentrations of keto-acids
The serum concentrations of keto-acids in a group of females and
males, measured using the method described here, are presented in
Tables
3 and
4. We observed no significant differences between females and
males in a given age group (Table 3
). In contrast, we report
for the first time a significant decrease in the concentrations of KIV,
KIC, and KMV in institutionalized patients
60 years of age (Table 4
). We found an inverse correlation between age and the
concentrations of KIC (P <0.0001), KIV (P
<0.001), and KMV (P <0.0001). The adult population studied
here was older than in other studies (17)(22),
which could explain why the BCKA values recorded for healthy
adults in our study were slightly lower than in other studies
(Table 5
). The decrease in the concentrations of KIV, KIC, and KMV with
increasing age may be related to the decrease in the lean muscular mass
observed during aging because most circulating BCKAs come from muscle
release (2)(6). Furthermore, it has been shown
that low serum albumin concentrations are associated with reduced
muscle mass in elderly people (23), and the lower albumin
concentrations observed in elderly people (24) could explain
this decrease in the BCKA concentrations. This hypothesis is supported
by the fact that BCKAs are extensively bound to albumin: less than
one-half of plasma BCKAs are ultrafiltrable
(25)(26). It is therefore useful to determine
the reference values of keto-acids as a function of albumin
concentrations. In our study, the albumin concentration of the
institutionalized elderly people was 35.4 ± 6.0 g/L (reference
values in our laboratory, 40 ± 5 g/L). Supporting the hypothesis
expressed above, we found a significant correlation between the albumin
and KIC concentrations [KIC = 0.595(albumin) - 2.538;
r = 0.499; z = 3.379; P
<0.001], KIV concentrations [KIV = 0.215(albumin) + 3.309;
r = 0.441; z = 2.921; P
<0.01], and KMV concentrations [KMV = 0.294(albumin) + 3.268;
r = 0.368; z = 2.378; P
<0.05]. Finally, PYR, which does not bind to albumin, was not
decreased in elderly subjects compared with adults 1959 years of age.
|
|
|
In conclusion, the technique described in this report, although it includes a derivatization step, does not require long and complicated preparation of the samples. Chromatographic separation of four keto-acids is performed at a high flow rate of 1.6 mL/min at 50 °C, affording good separation of the peaks, good recoveries, and shorter retention times than other techniques described previously. With this method, 20 sera can be prepared (~75 min) and analyzed (12 min per sample) in <6 h. This technique, linear up to 3 mmol/L, enables the determination of widely different quantities of keto-acids, as observed for patients with metabolic disorders or suffering from various diseases (e.g., urea-cycle enzyme defects, uremia, hepatic encephalopathy). This study also showed that elderly institutionalized people have lower concentrations of BCKAs than younger adults, but similar concentrations of pyruvate. In view of the binding between BCKAs and albumin, it seems important to take the serum albumin concentration into consideration for the interpretation of BCKA assays in the elderly. A complementary study with noninstitutionalized elderly people needs to be performed to evaluate the effect of age on BCKA concentrations.
| Footnotes |
|---|
-ketoisocaproate; KIV,
-ketoisovalerate; KMV,
-keto-ß-methylvalerate; PYR, pyruvate; KV, ketovalerate; OPD, o-phenylenediamine; and IS, internal standard. | References |
|---|
|
|
|---|
-ketoacids on the metabolism of isolated rat liver cells. I. Regulation of branched chain
-ketoacid metabolism. J Biol Chem 1979;254:11511-11520.
-ketoisocaproic acid in isolated perfused liver of cirrhotic rats. Am J Physiol 1995;268:E298-E304.
-keto acids in blood by gas chromatography. J Chromatogr 1982;231:237-245.
[Web of Science][Medline]
[Order article via Infotrieve]
-keto acids analysis in biological fluids: preparative clean-up by anion-exchange and analysis by capillary gas chromatography. J Chromatogr 1984;310:1-10.
[Web of Science][Medline]
[Order article via Infotrieve]
-keto acids as their trimethylsilylated oximes. Clin Chim Acta 1973;48:279-285.
[Web of Science][Medline]
[Order article via Infotrieve]
-keto acids in serum and urine by high-performance liquid chromatography. Anal Biochem 1984;141:481-487.
[Web of Science][Medline]
[Order article via Infotrieve]
-keto acids in plasma by high-performance liquid chromatography. J Chromatogr 1982;232:170-175.
[Web of Science][Medline]
[Order article via Infotrieve]
-keto acids including phenylpyruvic acid in human plasma by high-performance liquid chromatography with chemiluminescence detection. Anal Biochem 1990;190:309-313.
[Web of Science][Medline]
[Order article via Infotrieve]
-keto acids in plasma with fluorometric detection. J Chromatogr 1983;273:245-252.
[Web of Science][Medline]
[Order article via Infotrieve]
-keto acids in human serum and urine using 1,2-diamino-4,5-methylenedioxybenzene as a precolumn fluorescence derivatization reagent. J Chromatogr 1988;430:223-231.
[Web of Science][Medline]
[Order article via Infotrieve]
-keto acids in serum and urine by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1985;344:33-39.
[Web of Science][Medline]
[Order article via Infotrieve]
-ketoisocaproate binding to albumin in vivo by free fatty acids. Am J Physiol 1982;242:E67-E71.
The following articles in journals at HighWire Press have cited this article:
![]() |
Y. Liu, G. L. Borchert, S. P. Donald, B. A. Diwan, M. Anver, and J. M. Phang Proline Oxidase Functions as a Mitochondrial Tumor Suppressor in Human Cancers Cancer Res., August 15, 2009; 69(16): 6414 - 6422. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Barea, L. Brossard, N. Le Floc'h, Y. Primot, D. Melchior, and J. van Milgen The standardized ileal digestible valine-to-lysine requirement ratio is at least seventy percent in postweaned piglets J Anim Sci, March 1, 2009; 87(3): 935 - 947. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |